Skip to content
value.today

Cardiac Insight, Inc.

Total raised
$33 M
8 rounds on record
Latest round
$12 M
Mar 2022
First round on record
Aug 2013
Today
Private
No later event on record

Funding rounds

8 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Cardiac Insight, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2022$12 MNo. 8$10 to $50 million

Cardiac Insight, Inc.: Raise no. 8, Mar 2022

Investors in this round

6 investors had bought by the notice of Mar 31, 2022: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered; $1 M still to sell
Smallest investment taken
$20,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Ann Demaree · Executive Officer
  • Daniel Tylutki · Executive Officer
  • David Hadley · Executive Officer
  • Hyoung Min Kim · Executive Officer, Director
  • Kurt Noltensmeyer · Executive Officer
  • Michael Schuh · Executive Officer
  • Robert Odell · Executive Officer
  • Stacy Sprouse · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hyoung Min Kim, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 31, 2022. Read the notice at the SEC.

debt, optionsSEC
Jul 2019$5 MNo. 7$2 to $10 million

Cardiac Insight, Inc.: Raise no. 7, Jul 2019

Investors in this round

12 investors had bought by the notice of Aug 14, 2019: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $12 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bob Odell · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • Mike Schuh · Executive Officer
  • Clifford Stocks · Director
  • Kirby Cramer · Director
  • Richard Martin · Director
  • Robert deGavre · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 14, 2019. Read the notice at the SEC.

equitySEC
May 2017$3 MNo. 6$2 to $10 million

Cardiac Insight, Inc.: Raise no. 6, May 2017

Investors in this round

31 investors had bought by the notice of Aug 15, 2017: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $10 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bill Willis · Executive Officer
  • Bob Odell · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • Mike Schuh · Executive Officer
  • Kirby Cramer · Director
  • Lex Gamble · Director
  • Richard Martin · Director
  • Robert Hauser · Director
  • Robert deGavre · Director
  • Tom Clement · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 15, 2017. Read the notice at the SEC.

equitySEC
Nov 2016$1 MNo. 5Under $2 million

Cardiac Insight, Inc.: Raise no. 5, Nov 2016

Investors in this round

1 investor had bought by the notice of Dec 6, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bill Willis · Executive Officer
  • Bob Odell · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • David Linker · Executive Officer, Director
  • Mike Schuh · Executive Officer
  • Hemanth Reddy · Director
  • Kirby Cramer · Director
  • Lex Gamble · Director
  • Richard Martin · Director
  • Robert Hauser · Director
  • Robert deGavre · Director
  • Tom Clement · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 6, 2016. Read the notice at the SEC.

equitySEC
Apr 2016$3 MNo. 4$2 to $10 million

Cardiac Insight, Inc.: Raise no. 4, Apr 2016

Investors in this round

30 investors had bought by the notice of Apr 27, 2016: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bill Willis · Executive Officer
  • Bob Odell · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • David Linker · Executive Officer, Director
  • Mike Schuh · Executive Officer
  • Hemanth Reddy · Director
  • Kirby Cramer · Director
  • Lex Gamble · Director
  • Richard Martin · Director
  • Robert Hauser · Director
  • Robert deGavre · Director
  • Tom Clement · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offering includes warrants, the monetary consideration for which may not be paid until the exercise of said warrants.”

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 27, 2016. Read the notice at the SEC.

debt, optionsSEC
Sep 2015$4 MIssued in a merger or acquisition$2 to $10 million

Cardiac Insight, Inc.: Private sale, Sep 2015

Investors in this round

2 investors had bought by the notice of Sep 21, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bill Willis · Executive Officer
  • Bob Odell · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • David Linker · Executive Officer, Director
  • Mike Schuh · Executive Officer
  • Robert deGavre · Executive Officer, Director
  • Hemanth Reddy · Director
  • Kirby Cramer · Director
  • Lex Gamble · Director
  • Richard Martin · Director
  • Robert Hauser · Director
  • Tom Clement · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 21, 2015. Read the notice at the SEC.

optionsSEC
Jun 2014$7 MNo. 3$2 to $10 million

Cardiac Insight, Inc.: Raise no. 3, Jun 2014

Investors in this round

2 investors had bought by the notice of Jul 7, 2014: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $9 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bill Willis · Executive Officer
  • Bob Odell · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • David Linker · Executive Officer, Director
  • Mike Schuh · Executive Officer
  • Robert deGavre · Executive Officer, Director
  • Kirby Cramer · Director
  • Lex Gamble · Director
  • Richard Martin · Director
  • Robert Hauser · Director
  • Tom Clement · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 7, 2014. Read the notice at the SEC.

equitySEC
Jan 2014$2 MNo. 2$2 to $10 million

Cardiac Insight, Inc.: Raise no. 2, Jan 2014

Investors in this round

1 investor had bought by the notice of Jan 23, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bill Willis · Executive Officer
  • Bob Odell · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • David Linker · Executive Officer, Director
  • Mike Schuh · Executive Officer
  • Robert deGavre · Executive Officer, Director
  • Kirby Cramer · Director
  • Lex Gamble · Director
  • Richard Martin · Director
  • Robert Hauser · Director
  • Tom Clement · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 23, 2014. Read the notice at the SEC.

debt, optionsSEC
Aug 2013$1 MNo. 1Under $2 million

Cardiac Insight, Inc.: Raise no. 1, Aug 2013

Investors in this round

29 investors had bought by the notice of Aug 13, 2013: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Bill Willis · Executive Officer
  • Brad Harlow · Executive Officer, Director
  • David Linker · Executive Officer, Director
  • Robert deGavre · Executive Officer, Director
  • Kirby Cramer · Director
  • Lex Gamble · Director
  • Richard Martin · Director
  • Robert Hauser · Director
  • Tom Clement · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes warrants, the exercise price of which has not been received, and may never be received.”

Signed by Brad Harlow, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 13, 2013. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cardiac Insight, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2022).

    SEC Form D · Mar 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2022

That is all the official record says: Cardiac Insight, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cardiac Insight, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 8 rounds above had up to 31 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cardiac Insight, Inc.
NameRoleNamed in
Ann DemareeExecutive officerMar 2022
Daniel TylutkiExecutive officerMar 2022
David HadleyExecutive officerMar 2022
Hyoung Min KimExecutive officerMar 2022
Kurt NoltensmeyerExecutive officerMar 2022
Michael SchuhExecutive officerMar 2022
Robert OdellExecutive officerMar 2022
Stacy SprouseExecutive officerMar 2022
Bob OdellExecutive officerAug 2019
Brad HarlowExecutive officerAug 2019
Mike SchuhExecutive officerAug 2019
Bill WillisExecutive officerAug 2017
David LinkerExecutive officerDec 2016
Robert deGavreExecutive officerSep 2015
Hyoung Min KimDirectorMar 2022
Brad HarlowDirectorAug 2019
Clifford StocksDirectorAug 2019
Kirby CramerDirectorAug 2019
Richard MartinDirectorAug 2019
Robert deGavreDirectorAug 2019
Lex GambleDirectorAug 2017
Robert HauserDirectorAug 2017
Tom ClementDirectorAug 2017
David LinkerDirectorDec 2016
Hemanth ReddyDirectorDec 2016